Abhay H Pande

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Recombinant Human

Nitric Oxide Synthase

Top Venues

Medical oncology (Northwood, London, England)

Protein and peptide letters

This page only lists publications with an associated author ORCID identifier.

Publications

A R Satvik Iyengar, Prakash Y Khandave, Janek Bzdrenga, Florian Nachon, Xavier Brazzolotto, Abhay H Pande
Warfare Nerve Agents and Paraoxonase-1 as a Potential Prophylactic Therapy against Intoxication. Protein and peptide letters 31 (5) (2024)
A R Satvik Iyengar, Prakash Y Khandave, Janek Bzdrenga, Florian Nachon, Xavier Brazzolotto, Abhay H Pande
Warfare Nerve Agents and Paraoxonase-1 as a Potential Prophylactic Therapy against Intoxication. Protein and peptide letters (2024)
null Sandeep, Suraj H Shinde, Sakeel Ahmed, Shyam Sunder Sharma, Abhay H Pande
Engineered polyspecific antibodies: A new frontier in the field of immunotherapeutics. Immunology (2023)
null Sandeep, Suraj H Shinde, Sakeel Ahmed, Shyam Sunder Sharma, Abhay H Pande
Engineered polyspecific antibodies: A new frontier in the field of immunotherapeutics. Immunology 171 (4) (2023)
J Anakha, Prakashkumar Dobariya, Shyam Sunder Sharma, Abhay H Pande
Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status. Medical oncology (Northwood, London, England) 41 (1) (2023)
J Anakha, Prakashkumar Dobariya, Shyam Sunder Sharma, Abhay H Pande
Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status. Medical oncology (Northwood, London, England) 41 (1) (2023)
J Anakha, Yenisetti Rajendra Prasad, Nisha Sharma, Abhay H Pande
Human arginase I: a potential broad-spectrum anti-cancer agent. 3 Biotech 13 (5) (2023)
J Anakha, Yenisetti Rajendra Prasad, Nisha Sharma, Abhay H Pande
Human arginase I: a potential broad-spectrum anti-cancer agent. 3 Biotech 13 (5) (2023)
J Anakha, Prakashkumar Dobariya, Shyam Sunder Sharma, Abhay H Pande
Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status. Medical oncology (Northwood, London, England) 41 (1) (2023)
J Anakha, Yenisetti Rajendra Prasad, Nisha Sharma, Abhay H Pande
Human arginase I: a potential broad-spectrum anti-cancer agent. 3 Biotech 13 (5) (2023)
J Anakha, Yenisetti Rajendra Prasad, Nisha Sharma, Abhay H Pande
Human arginase I: a potential broad-spectrum anti-cancer agent. 3 Biotech 13 (5) (2023)
null Sandeep, Suraj H Shinde, Sakeel Ahmed, Shyam Sunder Sharma, Abhay H Pande
Engineered polyspecific antibodies: A new frontier in the field of immunotherapeutics. Immunology 171 (4) (2023)
J Anakha, Priyanka S Kawathe, Sayantap Datta, Snehal Sainath Jawalekar, Uttam Chand Banerjee, Abhay H Pande
Human arginase 1, a Jack of all trades? 3 Biotech 12 (10) (2022)
Dharam Pal, Gopal Patel, Prakashkumar Dobariya, Shivraj Hariram Nile, Abhay H Pande, Uttam Chand Banerjee
Optimization of medium composition to increase the expression of recombinant human interferon-β using the Plackett-Burman and central composite design in E. coli SE1. 3 Biotech 11 (5) (2021)
A R Satvik Iyengar, Abhay H Pande
Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead. The protein journal 35 (6) (2017)
Dharam Pal, Rajan K Tripathy, Madaka Surya Teja, Mukesh Kumar, Uttam Chand Banerjee, Abhay H Pande
Antibiotic-free expression system for the production of human interferon-beta protein. 3 Biotech 8 (1) (2017)